Oaktree Acquisition Corp III Life Sciences Unit
OACCU
5 hedge funds and large institutions have $9.02M invested in Oaktree Acquisition Corp III Life Sciences Unit in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more capital invested
Capital invested by funds: $8.99M → $9.02M (+$22K)
0.01% more ownership
Funds ownership: 4.69% → 4.7% (+0.01%)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$20.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$194 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
ADAR1 Capital Management
Austin,
Texas
| $5.49M | – | – | – |
|
|
AAA
2
Affinity Asset Advisors
New York
| $2.65M | – | – | – |
|
|
AC
3
Athos Capital
Hong Kong
| $536K | – | – | – |
|
|
CS
4
Clear Street
New York
| $238K | +$20.3K | +1,888 | +9% |
|
|
5
UBS Group
Zurich,
Switzerland
| $104K | -$194 | -18 | -0.2% |
|
OACCU Hedge Fund Activity: Q4 2025 in Review
5 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Oaktree Acquisition Corp III Life Sciences Unit (OACCU) for Q4 2025, worth a combined $9.02M — up 0.24% from $8.99M a quarter earlier.
Fund positioning in OACCU was balanced in Q4 2025: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Clear Street, adding an estimated $20.3K. The largest seller was UBS Group, cutting an estimated $194.
- 5 institutional investors held Oaktree Acquisition Corp III Life Sciences Unit (OACCU) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $9.02M of Oaktree Acquisition Corp III Life Sciences Unit stock for Q4 2025, up 0.24% quarter-over-quarter.
- 0 funds opened new Oaktree Acquisition Corp III Life Sciences Unit positions in Q4 2025 and 0 closed out.
- The largest Oaktree Acquisition Corp III Life Sciences Unit buyer in Q4 2025 was Clear Street, an estimated $20.3K added.
- The largest Oaktree Acquisition Corp III Life Sciences Unit seller in Q4 2025 was UBS Group, an estimated $194 sold.
Based on aggregated 13F filings for Q4 2025.